Gene Therapy for Treatment of Hemophilia: An Introduction to Adeno-Associated Viral Vector Gene Transfer

Gene Therapy for Treatment of Hemophilia: An Introduction to Adeno-Associated Viral Vector Gene Transfer

Gene Therapy for Treatment of Hemophilia: An Introduction to Adeno-Associated Viral Vector Gene Transfer

mod6 post

Transcripts/Translations Available

A comprehensive educational resource designed by leading experts for the global hemophilia community to help you stay abreast of the evolving science and latest clinical advancements in gene therapy in hemophilia.

 

Click to Begin!

Johnny Mahlangu, BSc, MBBCh, MMed, FCPath

Johnny Mahlangu, BSc, MBBCh, MMed, FCPath
Faculty of the Health Sciences
University of the Witwatersrand and National Health Laboratory Service
Johannesburg, South Africa

Johnny Mahlangu, BSc, MBBCh, MMed, FCPath is a Personal Professor in Haematology and Head of School of Pathology in the Faculty of Health Sciences of the University of the Witwatersrand and the National Health Laboratory Service in Johannesburg, South Africa. He is also Director of the International Haemophilia Training Centre and Consultant Clinical Haematologist at the Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg. Dr Mahlangu received his undergraduate and postgraduate training in science and medicine at the University of the Witwatersrand with haematology specialist and clinical haematology sub-specialist qualifications through the Colleges of Medicine of South Africa. He has published many journal articles and abstracts and has delivered lectures, workshops, and presentations at national and international meetings. His main area of research is novel therapies in bleeding disorders in which he has served as Principal Investigator for over 70 international multicenter studies. Professor Mahlangu is the current President of the College of Pathologists in South Africa, board member of the South African Medical Research Council, Wits Health Consortium and Poliomyelitis Research Foundation and Chair of the International Society of Thrombosis and Haemostasis (ISTH) Scientific and Standardization Committee on Factor VIII, FIX and rare bleeding disorders.

CME/CE credit is no longer available for this activity.

Click to Begin

Getting to Know Gene Therapy– Terminology and Concepts

Click to Begin!

Image

Supported through educational grants from BioMarin, CSL Behring, Pfizer Inc., Roche, and Spark Therapeutics

Essential SSL